Patient Education
Fruquintinib: A New Medicine for mCRC Recommended for Approval in Europe
DiCE supports the recommendation for approval of fruquintinib, a new medicine for metastatic colorectal cancer (mCRC). This medicine offers mCRC pa...
OECD Report Confirms Inequalities in Cancer
Cancer causes almost a quarter of all deaths in the EU27, Norway and Iceland, with five new cancer cases diagnosed every minute in 2022. Assessing ...
Positive Response to New Neoadjuvant Treatment Combination for Gastric and Gastroesophageal Cancer
In a recently published study conducted by the Netherlands Cancer Institute, patients with gastric (stomach) cancer or gastroesophageal junction (G...
Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA)
Researchers in Italy have written a helpful and very detailed review of biomarkers specific to iCCA. Biomarkers are measurable medical signs that c...
COR2ED’s New Resources on Advanced HCC
COR2ED is an independent medical education company that develops impactful educational programmes within specific therapeutic areas. They have rece...
Lynch Syndrome, the Most Common of the Rarest
Next month is Lynch Syndrome Day, also known as Hereditary Non-Polyposis Colorectal Cancer, so we will remind people that those who have Lynch synd...
Act4Biosimilars: The Action Plan and Deep Dive Report for Europe are Now Live!
Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater Approvability, Accessibility, Acce...
3rd International Symposium on Pancreatic Cancer
On 16-18 October, French researchers from the AFRCP (Association Française pour la Recherche sur le Cancer du Pancreas) organised the ‘Pancr...
DiCE Participants Complete Patient Expert Training
We are thrilled to announce that two participants from Digestive Cancers Europe (DiCE) completed the EUPATI Patient Expert Training Programme in Pr...
New Expert Advisor on CRC Screening
We are delighted to welcome Dr. Carlo Senore as our new advisor for colorectal cancer screening. Dr. Senore brings a wealth of expertise to our org...
